IMNM EBITDA Margin
Immunome Inc · EBITDA Margin
IMNM EBITDA Margin
Latest reported-5519.58%period ending
IMNM TTM EBITDA Margin (-1221.24% → -5519.58%)
TTM ebitda margin
High-resolution chart · PNG
IMNM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -5,519.5766% | |
| -3,017.4182% | |
| -2,017.9564% | |
| -1,444.4277% | |
| -1,574.2% | |
| -1,674.0847% | |
| -1,085.4477% | |
| -657.2608% | |
| -341.0471% | |
| -194.7139% | |
| -208.2712% | |
| -384.2915% | |
| -1,221.2352% |